Application of urinary proteomics as possible risk predictor of renal and cardiovascular complications in patients with type 2-diabetes and microalbuminuria.

[1]  J. C. He.  Diabetic Kidney Disease , 2019, Kidney Protection.

[2]  H. Parving,et al.  Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria , 2018, Cardiovascular Diabetology.

[3]  O. Pedersen,et al.  Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits. , 2017, Kidney international.

[4]  J. Shaw,et al.  Prediction of acute coronary syndromes by urinary proteome analysis , 2017, PloS one.

[5]  C. Delles,et al.  Urinary Proteomics for Diagnosis and Monitoring of Diabetic Nephropathy , 2016, Current Diabetes Reports.

[6]  O. Pedersen,et al.  Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial , 2016, Diabetologia.

[7]  H. Parving,et al.  Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 study , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  A. Vlahou,et al.  A urinary proteome‐based classifier for the early detection of decline in glomerular filtration , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  A. Dominiczak,et al.  Urine proteomics in the diagnosis of stable angina , 2016, BMC Cardiovascular Disorders.

[10]  H. Mischak,et al.  Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial , 2016, BMJ Open.

[11]  A. Vlahou,et al.  Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides. , 2015, Journal of the American Society of Nephrology : JASN.

[12]  J. Staessen,et al.  The urinary proteome as correlate and predictor of renal function in a population study. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  M. Cooper,et al.  New insights into the use of biomarkers of diabetic nephropathy. , 2014, Advances in chronic kidney disease.

[14]  B. Kasiske,et al.  Diabetic Kidney Disease– A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO) , 2014, Kidney international.

[15]  J. Ioannidis,et al.  Technical aspects and inter-laboratory variability in native peptide profiling: the CE-MS experience. , 2013, Clinical biochemistry.

[16]  H. Mischak,et al.  A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus , 2013, Diabetologia.

[17]  R. MacIsaac,et al.  Urinary Proteomics for Early Diagnosis in Diabetic Nephropathy , 2012, Diabetes.

[18]  A. Dominiczak,et al.  Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals , 2010, Journal of hypertension.

[19]  Harald Sourij,et al.  Multicentric Validation of Proteomic Biomarkers in Urine Specific for Diabetic Nephropathy , 2010, PloS one.

[20]  M. Girolami,et al.  Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease* , 2010, Molecular & Cellular Proteomics.

[21]  O. Pedersen,et al.  Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study , 1999, The Lancet.

[22]  H. Mischak,et al.  Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease. , 2009, Journal of proteome research.